Equities research analysts at StockNews.com began coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report released on Tuesday. The brokerage set a “sell” rating on the stock. Oragenics Stock Performance Shares of NYSE OGEN opened at $1.08 on Tuesday. The firm’s fifty day moving average price is $2.04. The company has […] Read this story